Stock ASC ASCENDIS HEALTH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Ascendis Health Limited

Equities

ASC

ZAE000185005

Pharmaceuticals

End-of-day quote Johannesburg S.E.
Other stock markets
 06:00:00 2024-04-21 pm EDT 		5-day change 1st Jan Change
0.8 ZAR 0.00% Intraday chart for Ascendis Health Limited 0.00% +2.56%
Mar. 29 Ascendis Health Seeks Acquisitions CI
Mar. 28 Ascendis Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI

Business Summary

Ascendis Health Limited specializes in developing, manufacturing and marketing care and health products. Net sales break down by family of products as follows:

- pharmaceutical products (61.3%): primarily prescription drugs. The group also provides medical devices used in the radiology and surgery fields;

- consumer products (31%): OTC medicines, vitamins and minerals, homeopathic products, ayurvedic products, sports nutrition products, functional foods, etc.;

- care products for plants and animals (7.7%).

Net sales are distributed geographically as follows: South Africa (71.3%), Cyprus (16%) and Romania (12.7%).

Sales per Business

ZAR in Million2022Weight2023Weight Delta
Medical Devices
69.5 %
1,190 76.3 % 1,066 69.5 % -10.35%
Consumer Health Africa
30.5 %
638 40.9 % 469 30.5 % -26.45%
Pharma Africa
9.2 %
384 24.6 % 141 9.2 % -63.24%
Discontinued Operations
-9.2 %
-1,918 -123.0 % -141 -9.2 % -92.64%

Sales per region

ZAR in Million2022Weight2023Weight Delta
South Africa
109.2 %
2,477 158.9 % 1,676 109.2 % -32.33%
Discontinued Operations
-9.2 %
-1,918 -123.0 % -141 -9.2 % -92.64%

Managers

Managers TitleAgeSince
Carl Neethling CEO
 Chief Executive Officer - 22-06-12
Joseph Fine SEC
 Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Theunis de Bruyn BRD
 Director/Board Member 56 22-10-18
Bharti Harie CHM
 Chairman 53 22-06-12
Carl Neethling CEO
 Chief Executive Officer - 22-06-12
Karsten Wellner BRD
 Director/Board Member 63 21-12-19
Amaresh Chetty BRD
 Director/Board Member - 22-06-12

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 640,287,915 348,812,554 ( 54.48 %) 6,503,407 ( 1.016 %) 54.48 %

Shareholders

NameEquities%Valuation
Momentum Investment Group Pty Ltd.
0.3389 %
2,143,288 0.3389 % 91 690 R
Blakeney LLP
0.1930 %
1,220,979 0.1930 % 52 233 R
Theunis de Bruyn
0.1536 %
971,434 0.1536 % 41 558 R
Carl Neethling
0.1536 %
971,433 0.1536 % 41 558 R
Momentum Outcome-based Solutions (Pty) Ltd.
0.1442 %
911,857 0.1442 % 39 009 R
Excelsia Capital Pty Ltd.
0.0418 %
264,549 0.0418 % 11 317 R
Momentum Asset Management Pty Ltd.
0.0168 %
106,243 0.0168 % 4 545 R
Clarus Asset Managers (Pty) Ltd.
0.009094 %
57,516 0.009094 % 2 461 R
Old Mutual Customised Solutions (Pty) Ltd.
0.004347 %
27,493 0.004347 % 1 176 R
Cannon Asset Managers Pty Ltd.
0.003551 %
22,461 0.003551 % 961 R

Company contact information

Ascendis Health Ltd.

1 Carey Street Bryanston

2090, Cape Town

+

http://ascendishealth.com
address Ascendis Health Limited(ASC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ASCENDIS HEALTH LIMITED Stock Ascendis Health Limited
+2.56% 26.14M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.46% 659B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.97% 557B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.86% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.44% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.34% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+6.30% 215B
NOVARTIS AG Stock Novartis AG
+7.81% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.05% 200B
PFIZER, INC. Stock Pfizer, Inc.
-8.79% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ASC Stock
  4. Company Ascendis Health Limited